Arthritis patients should be screened for latent tuberculosis infection before starting biologics because treatment may cause reactivation of TB, the Australian Rheumatology Association has reminded clinicians. While the risk of latent tuberculosis may appear to be low for many Australian patients, screening with questions on potential exposure factors such as overseas residency, healthcare employment and ...
Screen all patients for latent TB to avoid reactivation: ARA
By Michael Woodhead
6 Feb 2018